Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma

被引：1
|
作者：
Ageenko, Alisa [1 ]
Vasileva, Natalia [1 ,2 ]
Richter, Vladimir [1 ]
Kuligina, Elena [1 ,2 ]
机构：
[1] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Akad Lavrentiev Ave 8, Novosibirsk 630090, Russia
[2] LLC Oncostar, R&D Dept, Ingenernaya St 23, Novosibirsk 630090, Russia
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2024年 / 25卷 / 04期
基金：
俄罗斯科学基金会;
关键词：
glioblastoma; oncolytic viruses; chemotherapy; radiotherapy; immunotherapy; combination therapy; HERPES-SIMPLEX-VIRUS; MEASLES-VIRUS; MALIGNANT GLIOMA; VACCINIA VIRUS; RADIATION-THERAPY; MYXOMA VIRUS; PRECLINICAL EVALUATION; CANCER-CELLS; PHASE-I; GM-CSF;
D O I：
10.3390/ijms25042042
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Glioblastoma is one of the most malignant and aggressive tumors of the central nervous system. Despite the standard therapy consisting of maximal surgical resection and chemo- and radiotherapy, the median survival of patients with this diagnosis is about 15 months. Oncolytic virus therapy is one of the promising areas for the treatment of malignant neoplasms. In this review, we have focused on emphasizing recent achievements in virotherapy, both as a monotherapy and in combination with other therapeutic schemes to improve survival rate and quality of life among patients with glioblastoma.
引用
收藏
页数：26
相关论文
共 50 条
  • [41] Synergistic combination of oncolytic virotherapy with CAR T-cell therapy
    Ajina, Adam
    Maher, John
    CANCER IMMUNOTHERAPY, 2019, 164 : 217 - 292
  • [42] Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy
    Spencer, Drew A.
    Young, Jacob S.
    Kanojia, Deepak
    Kim, Julius W.
    Polster, Sean P.
    Murphy, Jason P.
    Lesniak, Maciej S.
    THERAPEUTIC DELIVERY, 2015, 6 (04) : 453 - 468
  • [43] Surface engineering of oncolytic adenovirus for a combination of immune checkpoint blockade and virotherapy
    Lv, Peng
    Chen, Xiaomei
    Fu, Shiying
    Ren, En
    Liu, Chao
    Liu, Xuan
    Jiang, Lai
    Zeng, Yun
    Wang, Xiaoyong
    Liu, Gang
    BIOMATERIALS SCIENCE, 2021, 9 (22) : 7392 - 7401
  • [44] Oncolytic virotherapy combination with DC-based immunotherapy for the treatment of melanoma
    Banki, Zoltan
    Koske, Iris
    Barnstorf, Isabel
    Tripp, Christoph
    Stoitzner, Patrizia
    Romani, Nikolaus
    Wollmann, Guido
    Kimpel, Janine
    Holm-von Laer, Dorothee
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [45] Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma
    Li, Hongtao
    Dutuor, Aurelie
    Tao, Lihua
    Fu, Xinping
    Zhang, Xiaoliu
    CLINICAL CANCER RESEARCH, 2007, 13 (01) : 316 - 322
  • [46] Synergistic mechanisms against pediatric bone sarcoma models: Trabectedin enhances oncolytic virotherapy intratumoral spread and antitumor immune activation
    Ringwalt, Emily
    Currier, Mark
    Glaspell, Andrea
    Cannon, Matthew V.
    Chen, Chun-Yu
    Gross, Amy C.
    Cam, Maren
    Wang, Pin-Yi
    Roberts, Ryan D.
    Cripe, Timothy P.
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction
    Yamakawa, Yasuaki
    Tazawa, Hiroshi
    Hasei, Joe
    Osaki, Shuhei
    Omori, Toshinori
    Sugiu, Kazuhisa
    Komatsubara, Tadashi
    Uotani, Kouji
    Fujiwara, Tomohiro
    Yoshida, Aki
    Kunisada, Toshiyuki
    Urata, Yasuo
    Kagawa, Shunsuke
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2017, 108 (09) : 1870 - 1880
  • [48] Angiogenesis Inhibition with Bevacizumab Increases the Antitumor Activity of Oncolytic Measles Virus Strains Against Glioblastoma Multiforme
    Opyrchal, Mateusz
    Allen, Cory
    Schroeder, Mark
    Carlson, Brett
    Sarkaria, Jann
    Russell, Stephen J.
    Galanis, Evanthia
    MOLECULAR THERAPY, 2009, 17 : S99 - S99
  • [49] Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
    Stepanenko, Aleksei A.
    Chekhonin, Vladimir P.
    CANCERS, 2018, 10 (12)
  • [50] Oncolytic virotherapy to enhance BiTE and CAR efficacy against solid tumours
    Heidbuechel, J. P. W.
    Speck, T.
    Veinalde, R.
    Abate-Daga, D.
    Jaeger, D.
    von Kalle, C.
    Ungerechts, G.
    Engeland, C. E.
    HUMAN GENE THERAPY, 2017, 28 (12) : A34 - A35
12345